Skip to Main Content

Paper Details

Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial.
Ann Rheum Dis
45
2020
Author NameAffiliation
Marc C HochbergUniversity of Maryland School of Medicine
  • 1 - 1

Datasets

Release 1.2